↓ Skip to main content

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

Overview of attention for article published in American Journal of Neuroradiology, November 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
22 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
278 Dimensions

Readers on

mendeley
363 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
Published in
American Journal of Neuroradiology, November 2015
DOI 10.3174/ajnr.a4539
Pubmed ID
Authors

A. Traboulsee, J.H. Simon, L. Stone, E. Fisher, D.E. Jones, A. Malhotra, S.D. Newsome, J. Oh, D.S. Reich, N. Richert, K. Rammohan, O. Khan, E.-W. Radue, C. Ford, J. Halper, D. Li

Abstract

An international group of neurologists and radiologists developed revised guidelines for standardized brain and spinal cord MR imaging for the diagnosis and follow-up of MS. A brain MR imaging with gadolinium is recommended for the diagnosis of MS. A spinal cord MR imaging is recommended if the brain MR imaging is nondiagnostic or if the presenting symptoms are at the level of the spinal cord. A follow-up brain MR imaging with gadolinium is recommended to demonstrate dissemination in time and ongoing clinically silent disease activity while on treatment, to evaluate unexpected clinical worsening, to re-assess the original diagnosis, and as a new baseline before starting or modifying therapy. A routine brain MR imaging should be considered every 6 months to 2 years for all patients with relapsing MS. The brain MR imaging protocol includes 3D T1-weighted, 3D T2-FLAIR, 3D T2-weighted, post-single-dose gadolinium-enhanced T1-weighted sequences, and a DWI sequence. The progressive multifocal leukoencephalopathy surveillance protocol includes FLAIR and DWI sequences only. The spinal cord MR imaging protocol includes sagittal T1-weighted and proton attenuation, STIR or phase-sensitive inversion recovery, axial T2- or T2*-weighted imaging through suspicious lesions, and, in some cases, postcontrast gadolinium-enhanced T1-weighted imaging. The clinical question being addressed should be provided in the requisition for the MR imaging. The radiology report should be descriptive, with results referenced to previous studies. MR imaging studies should be permanently retained and available. The current revision incorporates new clinical information and imaging techniques that have become more available.

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 363 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Netherlands 1 <1%
United States 1 <1%
Brazil 1 <1%
Unknown 359 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 52 14%
Other 42 12%
Student > Ph. D. Student 37 10%
Student > Postgraduate 33 9%
Student > Master 31 9%
Other 89 25%
Unknown 79 22%
Readers by discipline Count As %
Medicine and Dentistry 144 40%
Neuroscience 40 11%
Nursing and Health Professions 25 7%
Engineering 11 3%
Agricultural and Biological Sciences 8 2%
Other 34 9%
Unknown 101 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2022.
All research outputs
#875,409
of 24,652,720 outputs
Outputs from American Journal of Neuroradiology
#71
of 5,137 outputs
Outputs of similar age
#13,185
of 288,182 outputs
Outputs of similar age from American Journal of Neuroradiology
#1
of 113 outputs
Altmetric has tracked 24,652,720 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,137 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.